Doctor profile · Federal record
Dr. Megan Nixon, PA-C
Physician Assistant · Waco, TX
- NPI 1326502758
- Accepts Medicare
- MIPS 97.5 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5100 Franklin Ave Ste C
Waco, TX 767106922
(254) 265-7100
fax (254) 875-0449 - Additional location
-
1618 Canyon Creek Dr Ste 120
Temple, TX 765023273
Credentials & registration
- NPI registered
- January 2019 — 7 yrs on file
- Profile last updated
- September 18, 2023
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Texas #PA12606
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326502758. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
951
Distinct HCPCS
10
Medicare allowed
$38,576
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 394 | 79 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 142 | 124 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 106 | 100 | $42 | |
17110 |
Destruction of skin growth, 1-14 growths | 61 | 57 | $91 | |
11102 |
Biopsy of related skin growth, first growth | 50 | 50 | $72 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | 12 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 40 | 38 | $46 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 36 | 31 | $105 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 32 | 32 | $90 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 21 | 17 | $139 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 65. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$978
Transactions
22
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Kerecis Limited | 2 | $395.26 | |
| UCB, Inc. | 3 | $138.30 | |
| Janssen Biotech, Inc. | 2 | $95.94 | |
| PFIZER INC. | 3 | $61.91 | |
| Amgen Inc. | 3 | $60.67 | |
| GENZYME CORPORATION | 2 | $54.33 | |
| Novartis Pharmaceuticals Corporation | 2 | $50.73 | |
| ConvaTec Inc. | 1 | $37.08 | |
| LEO Pharma Inc. | 1 | $28.15 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $26.74 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $14.97 | |
| Incyte Corporation | 1 | $13.53 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
261
Patients
59
Total drug cost
$292,800
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dupixent Pen (Dupilumab) | Brand | 56 | 0 | $205,984 |
| Clobetasol Propionate | Generic | 53 | 19 | $2,771 |
| Ketoconazole | Generic | 40 | 14 | $753 |
| Triamcinolone Acetonide | Generic | 25 | 15 | $189 |
| Hydrocortisone | Generic | 19 | 11 | $365 |
| Doxycycline Hyclate | Generic | 18 | 0 | $425 |
| Hydroxyzine Hcl | Generic | 14 | 0 | $125 |
| Fluorouracil | Generic | 12 | 0 | $1,296 |
| Sotyktu (Deucravacitinib) | Brand | 12 | 0 | $79,013 |
| Tacrolimus | Generic | 12 | 0 | $1,879 |
Frequently asked questions
What is Dr. Megan Nixon's medical specialty?
Dr. Megan Nixon practices Physician Assistant in Waco, TX.
Where does Dr. Megan Nixon practice?
Dr. Megan Nixon practices at 5100 Franklin Ave Ste C, Waco, TX 767106922. Office phone: 2542657100.
What is Dr. Megan Nixon's NPI?
Dr. Megan Nixon's National Provider Identifier (NPI) is 1326502758, issued by NPPES.
Does Dr. Megan Nixon accept Medicare assignment?
Yes. Dr. Megan Nixon accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Megan Nixon commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.